Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Mindfulness program to help with symptoms in chronic graft-versus-host disease

Official title: Pilot Feasibility Study of Mindfulness-Based Intervention in Patients With Chronic Graft-Versus-Host Disease

Run by City of Hope Medical Center · NCT07733141 · Data updated 2026-11-12

A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment17 (estimated)
SponsorCity of Hope Medical Center
Academic / other
Locations1 site (Duarte, California)
StatusRecruiting
StartedMarch 1, 2027
Main results expectedApril 8, 2028
Study endsApril 8, 2028
Registry record updatedOctober 16, 2026
Trial IDNCT07733141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with moderate to severe chronic GVHD who can attend group sessions and understand English.

Probably not a fit

Individuals who cannot commit to the 8-week program, have severe psychiatric conditions, or have active uncontrolled illness may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests an 8-week mindfulness-based intervention (MBI) that includes weekly group sessions and a 1:1 session, plus a daily self-meditation goal, in adults with chronic GVHD. The study will measure feasibility (participation and adherence) and collect preliminary signals of efficacy, along with biospecimens and survey data. Participants attend in-person or virtual sessions and complete daily meditation as recommended. Blood samples are collected throughout the study to monitor biomarkers. The trial is conducted at City of Hope Medical Center with collaboration from the NCI.

Why it matters

Potential benefit: If successful, participants may experience reduced symptoms and improved quality of life through better emotional regulation and coping.

How similar studies have gone: Mindfulness-based approaches have shown signals of benefit in other chronic disease contexts, but this specific program in chronic GVHD is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented informed consent of the participant and/or legally authorized representative
* Willingness to participate in the study
* Willingness to attend in-person or virtual group sessions
* Ability to read and understand English (required for protocol therapy and planned survey)
* Age: ≥ 18 years
* Confirmed diagnosis of moderate/severe chronic graft-versus-host disease by National Institute of Health (NIH) criteria
* Karnofsky performance status ≥ 80

Exclusion Criteria:

* Previous participation in four or more sessions of mindfulness-based cognitive therapy (MBCT)/ mindfulness-based stress reduction (MBSR)
* An increase in anti-cGvHD medication (increased dosage or addition of a new medication) within 4 weeks prior to baseline evaluation
* Severe psychiatric comorbidities (active psychosis, suicidal ideation) as determined by primary investigator (PI)
* Concurrent malignancy, autoimmune disease, chronic infections, or other chronic inflammatory illness that might confound the results as determined by the PI
* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)

Where it's running

  • City of Hope Medical Center
    Duarte, California, United States
    Recruiting

Study contacts

  • Principal investigator: Amandeep Salhotra — City of Hope Medical Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.